These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 8567917)

  • 21. Incomplete protection of hamsters vaccinated with unlipidated OspA from Borrelia burgdorferi infection is associated with low levels of antibody to an epitope defined by mAb LA-2.
    Johnson BJ; Sviat SL; Happ CM; Dunn JJ; Frantz JC; Mayer LW; Piesman J
    Vaccine; 1995 Aug; 13(12):1086-94. PubMed ID: 7491816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of immunization with recombinant OspA on serologic tests for Lyme borreliosis.
    Fawcett PT; Rose CD; Budd SM; Gibney KM
    Clin Diagn Lab Immunol; 2001 Jan; 8(1):79-84. PubMed ID: 11139199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective efficacy of an oral vaccine to reduce carriage of Borrelia burgdorferi (strain N40) in mouse and tick reservoirs.
    Scheckelhoff MR; Telford SR; Hu LT
    Vaccine; 2006 Mar; 24(11):1949-57. PubMed ID: 16300863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T helper cell priming of mice to Borrelia burgdorferi OspA leads to induction of protective antibodies following experimental but not tick-borne infection.
    Zhong W; Gern L; Kramer M; Wallich R; Simon MM
    Eur J Immunol; 1997 Nov; 27(11):2942-7. PubMed ID: 9394822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protection against tick-transmitted Lyme disease in dogs vaccinated with a multiantigenic vaccine.
    Straubinger RK; Dharma Rao T; Davidson E; Summers BA; Jacobson RH; Frey AB
    Vaccine; 2001 Oct; 20(1-2):181-93. PubMed ID: 11567763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Demonstration of the ability of a canine Lyme vaccine to reduce the incidence of histological synovial lesions following experimentally-induced canine Lyme borreliosis.
    Grosenbaugh DA; Rissi DR; Krimer PM
    Vet Immunol Immunopathol; 2016 Nov; 180():29-33. PubMed ID: 27692092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reactivity of dog sera to whole-cell or recombinant antigens of Borrelia burgdorferi by ELISA and immunoblot analysis.
    Magnarelli LA; Levy SA; Ijdo JW; Wu C; Padula SJ; Fikrig E
    J Med Microbiol; 2001 Oct; 50(10):889-895. PubMed ID: 11599738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of recombinant OspA in two different Borrelia vaccines with respect to immunological response and its relationship to functional parameters.
    Grosenbaugh DA; De Luca K; Durand PY; Feilmeier B; DeWitt K; Sigoillot-Claude C; Sajous ML; Day MJ; David F
    BMC Vet Res; 2018 Oct; 14(1):312. PubMed ID: 30326885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi.
    Golde WT; Burkot TR; Piesman J; Dolan MC; Capiau C; Hauser P; Dequesne G; Lobet Y
    Vaccine; 1995 Apr; 13(5):435-41. PubMed ID: 7639011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral delivery of purified lipoprotein OspA protects mice from systemic infection with Borrelia burgdorferi.
    Luke CJ; Huebner RC; Kasmiersky V; Barbour AG
    Vaccine; 1997; 15(6-7):739-46. PubMed ID: 9178476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of multiple reactive protein species by immunoblotting after recombinant outer surface protein A lyme disease vaccination.
    Molloy PJ; Berardi VP; Persing DH; Sigal LH
    Clin Infect Dis; 2000 Jul; 31(1):42-7. PubMed ID: 10913394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant assay for serodiagnosis of Lyme disease regardless of OspA vaccination status.
    Gomes-Solecki MJ; Wormser GP; Schriefer M; Neuman G; Hannafey L; Glass JD; Dattwyler RJ
    J Clin Microbiol; 2002 Jan; 40(1):193-7. PubMed ID: 11773115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the protective borreliacidal antibody response in humans and hamsters after vaccination with a Borrelia burgdorferi outer surface protein A vaccine.
    Padilla ML; Callister SM; Schell RF; Bryant GL; Jobe DA; Lovrich SD; DuChateau BK; Jensen JR
    J Infect Dis; 1996 Oct; 174(4):739-46. PubMed ID: 8843211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple antigen target approach using the Accuplex4 BioCD system to detect Borrelia burgdorferi antibodies in experimentally infected and vaccinated dogs.
    Moroff S; Woodruff C; Woodring T; Sokolchik I; Lappin MR
    J Vet Diagn Invest; 2015 Sep; 27(5):581-8. PubMed ID: 26289718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serologic responses of dogs naturally exposed to or vaccinated against Borrelia burgdorferi infection.
    Barthold SW; Levy SA; Fikrig E; Bockenstedt LK; Smith AL
    J Am Vet Med Assoc; 1995 Dec; 207(11):1435-40. PubMed ID: 7493871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An OspA-based DNA vaccine protects mice against infection with Borrelia burgdorferi.
    Luke CJ; Carner K; Liang X; Barbour AG
    J Infect Dis; 1997 Jan; 175(1):91-7. PubMed ID: 8985201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of outer surface proteins A and C of Borrelia burgdorferi in Ixodes ricinus ticks removed from humans.
    Fingerle V; Liegl G; Munderloh U; Wilske B
    Med Microbiol Immunol; 1998 Oct; 187(2):121-6. PubMed ID: 9832327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice.
    Fikrig E; Telford SR; Barthold SW; Kantor FS; Spielman A; Flavell RA
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5418-21. PubMed ID: 1608951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of OspA vaccination on Lyme disease serologic testing.
    Aguero-Rosenfeld ME; Roberge J; Carbonaro CA; Nowakowski J; Nadelman RB; Wormser GP
    J Clin Microbiol; 1999 Nov; 37(11):3718-21. PubMed ID: 10523583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. OspA antibodies inhibit the acquisition of Borrelia burgdorferi by Ixodes ticks.
    de Silva AM; Fish D; Burkot TR; Zhang Y; Fikrig E
    Infect Immun; 1997 Aug; 65(8):3146-50. PubMed ID: 9234767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.